Department of Glaucoma, Changsha Aier Eye Hospital, Changsha, China.
Department of Ophthalmology, The Second Xiangya Hospital, Changsha, China.
J Ocul Pharmacol Ther. 2024 Sep;40(7):435-444. doi: 10.1089/jop.2023.0122. Epub 2024 Jul 24.
Although it is now understood that most antiglaucoma surgeries fail because of scarring of the filtering tract, the underlying mechanism remains to be elucidated. The present study investigated the mechanism by which the interleukin (IL)-22/IL-22 receptor alpha 1 (IL-22RA1) signaling pathway regulates scar formation in glaucoma patients. A total of 31 glaucoma patients who underwent trabeculectomy surgery with uncontrollable intraocular pressure because of scarring and 19 strabismus patients as the control patient group were included in the present study. ELISA was performed to measure the content of IL-22 in peripheral blood. Serum from patients was used to incubate human Tenon's capsule fibroblasts (HTFs) cells and IL-22 antibody rescued the effect of IL-22 on the biological functions. qPCR and Western blot were performed to determine IL-22RA1 mRNA and protein expression levels. Flow cytometry was performed to assess the cell cycle distribution and the Cell Counting Kit-8 assay was used to analyze cell proliferation. The ELISA assay revealed that the serum IL-22 level of glaucoma patients was significantly higher than the healthy group (29.80 ± 5.1 ng/µL vs. 5.21 ± 0.9 ng/µL). After incubation with patient serum, the proliferation and activation of human Tenon fibroblasts (HTFs) were promoted. IL-22 mediated the biological function of HTFs via directly binding IL-22RA1. Moreover, transfection of the siR-IL-22RA1 or IL-22RA1 gene resulted in significant antifibrosis or profibrosis in HTFs. When a signal transducer and activator of transcription (STAT) 3 inhibitor (BAY) was introduced to the IL-22RA1 overexpression group, IL-22-induced proliferation was reduced in HTFs. Additionally, glaucoma patients had increased levels of IL-22 expression following surgery. The IL-22/IL-22RA1/STAT3 signaling pathway promoted fibroblast cell proliferation and alpha-smooth muscle actin, potentially regulating fibrosis in glaucoma filtration tracts. Our results provide hitherto undocumented insights into the pathophysiology of postoperative scarring.
虽然现在已经了解到,大多数抗青光眼手术的失败是由于滤过道的瘢痕形成所致,但其中的潜在机制仍有待阐明。本研究旨在探讨白细胞介素(IL)-22/IL-22 受体α 1(IL-22RA1)信号通路在青光眼患者瘢痕形成中的调节机制。
本研究共纳入 31 例因瘢痕形成导致眼压控制不佳而行小梁切除术的青光眼患者和 19 例斜视患者作为对照组。采用酶联免疫吸附试验(ELISA)检测外周血中 IL-22 的含量。用患者血清孵育人 Tenon 囊成纤维细胞(HTFs),并用 IL-22 抗体挽救 IL-22 对生物功能的作用。采用 qPCR 和 Western blot 检测 IL-22RA1mRNA 和蛋白表达水平。采用流式细胞术评估细胞周期分布,采用细胞计数试剂盒-8(CCK-8)检测细胞增殖。
ELISA 检测结果显示,青光眼患者血清 IL-22 水平明显高于健康对照组(29.80±5.1ng/µL 比 5.21±0.9ng/µL)。用患者血清孵育后,人 Tenon 纤维母细胞(HTFs)的增殖和活化得到促进。IL-22 通过直接结合 IL-22RA1 介导 HTFs 的生物学功能。此外,转染 siR-IL-22RA1 或 IL-22RA1 基因后,HTFs 的纤维化明显减少。在引入 IL-22RA1 过表达组的信号转导和转录激活因子(STAT)3 抑制剂(BAY)后,IL-22 诱导的 HTFs 增殖减少。此外,青光眼患者术后 IL-22 表达水平升高。
IL-22/IL-22RA1/STAT3 信号通路促进成纤维细胞增殖和α-平滑肌肌动蛋白表达,可能调节青光眼滤过道的纤维化。本研究结果为术后瘢痕形成的病理生理学提供了前所未有的见解。